{
    "clinical_study": {
        "@rank": "122621", 
        "acronym": "TASSH", 
        "arm_group": [
            {
                "arm_group_label": "WHO CVD risk assessment package and Health Insurance", 
                "arm_group_type": "Active Comparator", 
                "description": "Arm#1 (Intervention Group): Provided Ghana's National Health insurance for 12 months. Intervention group will also receive the WHO Package delivered by trained community health nurses as part of the widespread Community based Health Planning and Services (CHPS) program in Ghana. The package includes CV risk assessment, BP readings,Medication adjustment, and  Behavioral counseling. Follow-up is at 3 months intervals for one-year and again at 24 months."
            }, 
            {
                "arm_group_label": "Health Insurance only", 
                "arm_group_type": "Sham Comparator", 
                "description": "Arm#2 (Control group): Provided Ghana's National Health Insurance for 12 months. Patients in this group will also receive brief behavioral counseling at baseline and continue with usual care. Follow-up is at 3 months intervals for one-year and again at 24 months."
            }
        ], 
        "brief_summary": {
            "textblock": "The goal of this study is to evaluate the comparative effectiveness of the World Health\n      Organization Package targeted at Cardiovascular (CV) risk assessment and hypertension\n      control, delivered by Community Health Nurses as part of Ghana's Community based Health\n      Planning and Services program, versus provision of health insurance coverage, on blood\n      pressure reduction. Findings from this study will provide policy makers and other\n      stakeholders needed information to recommend efficient cost-effective policy with regards to\n      comprehensive CV risk reduction in patients with hypertension in low resource settings."
        }, 
        "brief_title": "Task Shifting and Blood Pressure Control in Ghana", 
        "completion_date": {
            "#text": "March 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Hypertension", 
            "High Blood Pressure", 
            "Cardiovascular Diseases"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Cardiovascular Diseases", 
                "Hypertension"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Health facility Inclusion: Participating health facilities will be selected from\n             areas that are geographically distant from one another with equal urban/rural mix in\n             the Ashanti Region, which has 170 community health centers. Of these, we will recruit\n             32 for this study. Eligible facilities must have at least one community health nurse\n             employed in the CHPS program; be a certified NHIS provider; and have basic capability\n             for blood tests.\n\n          -  Patient Inclusion: To be eligible for the study, patients must fulfill the following\n             criteria: a) are registered to receive care at the health center; b) are adults age\n             40 years and older; c) have BP 140-179/90-100 mm Hg and are not on treatment for\n             hypertension; and c) can provide informed consent. Given low literacy levels, consent\n             will be provided both verbally and in written form.\n\n        Exclusion Criteria:\n\n        -Patients will be excluded if they have: a) previous diagnosis of diabetes, coronary\n        artery disease, transient ischemic attacks, stroke, heart failure, or angina: b)\n        BP>180/100 mm Hg; c) positive urine dipstick for protein; d) are pregnant; and e) unable\n        to comply with the follow-up requirements or provide informed consent. Patients with\n        history of transient ischemic attacks (TIAs), stroke, heart failure, diabetes, angina,\n        claudication, and BP>180/100 mm Hg will be referred to the district hospitals for further\n        management."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "640", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01802372", 
            "org_study_id": "1U01HL114198-01"
        }, 
        "intervention": [
            {
                "arm_group_label": "WHO CVD risk assessment package and Health Insurance", 
                "intervention_name": "WHO CVD risk assessment package and Health Insurance", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Health Insurance only", 
                "intervention_name": "Health Insurance only", 
                "intervention_type": "Behavioral"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Hypertension", 
            "High Blood Pressure", 
            "Cardiovascular Diseases", 
            "Health Insurance Coverage", 
            "Low income countries", 
            "Ghana", 
            "Low resource settings", 
            "Comparative Effectiveness"
        ], 
        "lastchanged_date": "January 23, 2014", 
        "location": {
            "contact": {
                "last_name": "Jacob Plange-Rhule, MB ChB, PhD"
            }, 
            "facility": {
                "address": {
                    "city": "Kumasi", 
                    "country": "Ghana"
                }, 
                "name": "Kwame Nkrumah University of Science and Technology"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Ghana"
        }, 
        "number_of_arms": "2", 
        "official_title": "Task Shifting and Blood Pressure Control in Ghana: A Cluster-Randomized Trial", 
        "overall_contact": {
            "email": "olugbenga.ogedegbe@nyumc.org", 
            "last_name": "Gbenga Ogedegbe, MD, MS, MPH"
        }, 
        "overall_contact_backup": {
            "email": "joyce.gyamfi@nyumc.org", 
            "last_name": "Joyce Gyamfi, MS"
        }, 
        "overall_official": {
            "affiliation": "NYU Langone Medical Center", 
            "last_name": "Gbenga Ogedegbe, MD, MS, MPH", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Ghana: Committee on Human Research", 
                "United States: Institutional Review Board", 
                "United States: Federal Government"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "BP control is defined as BP<140/90", 
            "measure": "Mean change in systolic Blood Pressure (BP)", 
            "safety_issue": "No", 
            "time_frame": "Baseline to 12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01802372"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Physical activity levels,change in weight,dietary intake of fruits and vegetables", 
            "safety_issue": "No", 
            "time_frame": "12 months and 24 months"
        }, 
        "source": "New York University School of Medicine", 
        "sponsors": {
            "collaborator": {
                "agency": "National Institutes of Health (NIH)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "New York University School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}